Bio-Rad Laboratories BIO Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's operating lease liabilities?
- Bio-Rad Laboratories (BIO) reported operating lease liabilities of $138.6M in Q1 2026.
- How has Bio-Rad Laboratories's operating lease liabilities changed year-over-year?
- Bio-Rad Laboratories's operating lease liabilities increased by 9.7% year-over-year, from $126.3M to $138.6M.
- What is the long-term trend for Bio-Rad Laboratories's operating lease liabilities?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's operating lease liabilities has grown at a -3.6% compound annual growth rate (CAGR), from $175.13M to $145.7M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.